A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.

Willey CD, Murphy BA, Netterville JL, Burkey BB, Shyr Y, Shakhtour B, Kish B, Raben D, Chen C, Song JI, Kane MA, Cmelak AJ
Int J Radiat Oncol Biol Phys. 2007 67 (5): 1323-31

PMID: 17289289 · DOI:10.1016/j.ijrobp.2006.11.033

MeSH Terms (21)

Adult Aged Antineoplastic Agents Combined Modality Therapy Disease-Free Survival Docetaxel Dose Fractionation, Radiation Erythropoietin Female Head and Neck Neoplasms Hemoglobin A Humans Male Middle Aged Mouth Mucosa Prospective Studies Radiation-Sensitizing Agents Radiation Injuries Radiotherapy Dosage Stomatitis Taxoids

Connections (1)

This publication is referenced by other Labnodes entities:

Links